JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS, vol.29, no.4, pp.410-413, 2013 (SCI-Expanded)
Purpose: To evaluate structural alterations of iris and pupil diameters (PDs) in patients using systemic alpha-1-adrenergic receptor antagonists (alpha-1ARAs), which are associated with intraoperative floppy iris syndrome (IFIS).